Healthcare -
Biotechnology - NASDAQ - US
$ 681.58
-1.68 %
$ 73.7 B
Market Cap
16.85
P/E
REGN - NET INCOME
Net Income REGN - Regeneron Pharmaceuticals, Inc.
3.95 B
LAST VALUE
-30.03%
2 YEAR CAGR
10.09%
5 YEAR CAGR
25.00%
10 YEAR CAGR